Clinical Trial Update: Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports that adding bismuth to a levofloxacin-containing triple therapy may improve Helicobacter pylori treatment efficacy. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)
• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Functional Dyspepsia, Peptic Ulcer | Phase 4 | Status: COMPLETED